From Collision to Collaboration: How Diagnostics, Pharma and Patients Can Succeed Together

Posted by Jim Adelizzi on August 31, 2017

Pavan Anne co-wrote this blog post with Jim Adelizzi.

In this new era of personalized medicine, matching the right patient with the right targeted therapy requires pharmaceutical and diagnostic companies to reach across industry lines and collaborate long before launch. Together, they need to create a strategy that enables the companion diagnostic to differentiate and accelerate the therapy rather than impede its growth. I’ve witnessed a few ways that these entities can create a go-to-market strategy in unison and carry that tight-knit collaboration all the way to market. To illustrate the inherent challenges, let’s consider the case of two fictional oncology companies that have entered into a research and commercialization agreement: Pharma Depot Co. and Diagnostics “R” Us Inc. 


>
Read More

Five Predictions for Medtech in 2016

Posted by Brian Chapman on December 16, 2015

The holidays are the perfect time for reflection. It’s time to think about the year and the accomplishments of the past, and especially to contemplate the future. It’s in this spirit that I want to offer my five predictions for medtech in 2016.


>
Read More

Break the Mold! Why Should I Follow Standard Consumer Marketing Practices?!?

Posted by Andy Kach on June 22, 2015

I opened my daily Groupon email the other week and was surprised to see a prescription medical device, contact lenses, being promoted as one of the daily deals. I thought to myself, Now that is clever! Even if not a single person purchased (although as of publication time, this offer has closed with more than 1,000 purchases), it is a clever way to market a medical device to consumers or patients. That got me thinking and talking to my colleagues about how medical device and diagnostic companies (or really any company!) can and should consider alternative means of promotion and pricing when trying to attract patients.


>
Read More

Benchmarks Can Be Dangerous!

Posted by Marshall Solem on June 16, 2015

In conversations with clients, I receive frequent requests for benchmarks on various aspects of running a commercial organization. Examples include:


>
Read More

Blurred Lines: Vertical Integration in the Medtech Sector

Posted by Tobi Laczkowski on June 9, 2015

A key question leaders in any company must face is how vertically integrated to be. This means deciding which links in the value chain they should operate, versus outsource to others. There are plenty of pros and cons to vertical integration. Often, the largest pros center around reducing the transaction costs in negotiations with suppliers or customers, as well as capturing the profits currently enjoyed by others along the value chain.


>
Read More